Mashang Fangxin (unofficially "Rest Easy Code Check"), which will serve brand manufacturers, distributors, government agencies, and consumers. ">

Get the free version of Marbridge Daily delivered to your inbox

Click here to subscribe

AliHealth Launches Third-party Product Tracking Platform

Yigoonet.com, 6/12/16

Chinese e-commerce conglomerate Alibaba Group's (NYSE: BABA) healthcare subsidiary Alibaba Health Information Technology (AliHealth) (0241.HK) recently launched a new third-party product tracking platform called Mashang Fangxin (unofficially "Rest Easy Code Check"), which will serve brand manufacturers, distributors, government agencies, and consumers. It will provide tracking services for manufacturers and distributors covering the entire product lifecycle and will also offer a public search interface to enable consumers to verify and track the history of various products. The platform will help government agencies at all levels to manage product quality control and safety.

The Mashang Fangxin platform will be compatible with the tracking standards used by the company's self-developed Product Identification, Authentication, and Tracking System (PIATS) and the China Drug Electronic Administration Platform to support free data migration for enterprises that used these platforms previously. The Mashang Fangxin website said that its public database searching and services offered to vaccine manufacturers will always be free, and that it will offer other enterprise users three years of free access to basic services including data migration, product code publication, and basic product flow tracking.

Editor's Note: In a phone interview with Marbridge, a Mashang Fangxin customer service representative confirmed that the platform will track a wide variety of products, including, but not limited to, pharmaceuticals. The representative could not confirm whether Mashang Fangxin is the same platform as the new third-party drug tracking platform AliHealth announced last month, but it is likely that it is, since the Mashang Fangxin platform allows pharmaceutical companies that had registered with PIATS and the China Drug Electronic Administration Platform to transfer their data to Mashang Fangxin.

For more information on AliHealth's previous announcement, please see "AliHealth to Launch New Third-party Drug Tracking Platform," MD 5/10/16 issue.

Keywords: Internet Product Identification Authentication and Tracking System Alibaba Group Alibaba Health 0241.HK BABA corporate user online healthcare

Feedback

Please note, all fields are required.
None of your personal information will be shared with third parties.

SendingSending

Disclaimer

The information contained in this newsletter is based upon sources that Marbridge Consulting believes to be reliable, and we have made every effort to translate the original articles or article excerpts as faithfully as possible. However, Marbridge Consulting makes no warranty of and assumes no legal responsibility for the accuracy of either the original source material or the English language translations.

Marbridge Daily Premium

Interested in gaining full access to all newsletter articles and the Marbridge Daily archive? To learn more about premium subscription options, including pricing, please:

Click here

Marbridge Consulting RSS Feed

Marbridge Reports